Ainos Inc AIMD

Healthcare Biotechnology

Ainos, Inc. is engaged in developing medical technologies for point-of-care (POCT) testing and medical treatment for a range of disease indications. The Company is engaged in the research and clinical development activities for its programs, securing related intellectual property, and commercializing therapeutics using low-dose non-injectable interferon (IFN). Its Medtech solutions includes COVID-19 Antigen Rapid Test Kit, Volatile Organic Compounds (VOC) POCT-Ainos Flora, VOC POCT-Ainos Pen, VOC POCT-CHS430, Very Low-Dose Oral Interferon Alpha (VELDONA) and Synthetic RNA (SRNA). Its Ainos Flora device is intended to perform a non-invasive test for female vaginal health and certain common sexually transmitted diseases (STDs). Ainos Pen device is a cloud-connected, multi-purpose, portable breath analyzer that is intended to monitor health conditions. The CHS430 device is intended to provide non-invasive testing for ventilator-associated pneumonia.

NDAQ:AIMD - Post by User

Ainos Inc

<< Previous

Bullboard Posts

Next >>

Post by mlnmanon Oct 24, 2024 8:41pm

40 Views

Post# 36281335

New research just dropped!

Exciting News!

WTR has just released a recap note on yesterday's Small-Cap Spotlight podcast featuring $AIMD. Here are the key highlights:

Safe, Oral Low-Dose Interferon-α ("IFN-α") Therapeutic
Extensive Clinical History
Rare Disease Focus
Animal Health Potential
Milestones for the Next 18 Months

Don't miss out! If you don't have access to the WTR website, head over to Ainos' IR website under the news section to get all the details. https://feeds.issuerdirect.com/news-release.html?newsid=4786114891531438